Abstract
Since the development of antibody phage display, 20 years ago, this technique has been evolved to a valuable and robust tool for the development of recombinant human antibodies. Today, this technique is widely used for the generation of antibodies for therapy and basic research. Automation processes and decrease of costs will enable the highthroughput design of monoclonal binders against a huge number of different antigens, presenting a valuable tool for proteome research. This review presents an overview on phage display technology and antibody libraries. The benefit of recombinant antibodies for basic research, diagnostic and therapy is shown.
Keywords: phage display, scFv, antibody, proteome research, antibody gene library, monoclonal antibody, human antibody, Humira, antibody genes, Murine antibodies, B-lymphocytes from, IgGs, E. coli, phagemid, bacteriophage M13
Current Biotechnology
Title: Generating Recombinant Antibodies for Research, Diagnostics and Therapy Using Phage Display
Volume: 1 Issue: 1
Author(s): Andre Frenzel, David Frode, Torsten Meyer, Thomas Schirrmann and Michael Hust
Affiliation:
Keywords: phage display, scFv, antibody, proteome research, antibody gene library, monoclonal antibody, human antibody, Humira, antibody genes, Murine antibodies, B-lymphocytes from, IgGs, E. coli, phagemid, bacteriophage M13
Abstract: Since the development of antibody phage display, 20 years ago, this technique has been evolved to a valuable and robust tool for the development of recombinant human antibodies. Today, this technique is widely used for the generation of antibodies for therapy and basic research. Automation processes and decrease of costs will enable the highthroughput design of monoclonal binders against a huge number of different antigens, presenting a valuable tool for proteome research. This review presents an overview on phage display technology and antibody libraries. The benefit of recombinant antibodies for basic research, diagnostic and therapy is shown.
Export Options
About this article
Cite this article as:
Frenzel Andre, Frode David, Meyer Torsten, Schirrmann Thomas and Hust Michael, Generating Recombinant Antibodies for Research, Diagnostics and Therapy Using Phage Display, Current Biotechnology 2012; 1 (1) . https://dx.doi.org/10.2174/2211550111201010033
DOI https://dx.doi.org/10.2174/2211550111201010033 |
Print ISSN 2211-5501 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-551X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Ribosome-inactivating Proteins from Root Tubers and Seeds of Trichosan-thes kirilowii and Other Trichosanthes Species
Protein & Peptide Letters DNA Microarrays - An Armory for Combating Infectious Diseases in the New Century
Infectious Disorders - Drug Targets Involvement of Membrane Channels in Autoimmune Disorders
Current Pharmaceutical Design STING Activation and its Application in Immuno-Oncology
Current Topics in Medicinal Chemistry Inhibition of West Nile virus Replication by Bifunctional siRNA Targeting the NS2A and NS5 Conserved Region
Current Gene Therapy HIV-1, Methamphetamine and Astrocyte Glutamate Regulation: Combined Excitotoxic Implications for Neuro-AIDS
Current HIV Research Epitope-Driven TB Vaccine Development: A Streamlined Approach Using Immuno-Informatics, ELISpot Assays, and HLA Transgenic Mice
Current Molecular Medicine Pharmacological Perspectives of Ayurvedic Herbs <i>viz. Alstonia scholaris</i> L., <i>Picrorhiza kurroa, Swertia chirata</i> and <i>Caesalpinia crista</i> Against COVID- 19: A Mini-Review
Mini-Reviews in Organic Chemistry Stairway to Heaven or Hell? Perspectives and Limitations of Chagas Disease Chemotherapy
Current Topics in Medicinal Chemistry In Silico Stereo-Electronic Analysis of PMD (p-Menthane-3-8-Diol) and its Derivatives for Pharmacophore Development May Aid Discovery of Novel Insect Repellents
Current Computer-Aided Drug Design Therapeutic Potential of Erythropoietin in Retinal and Optic Nerve Diseases
CNS & Neurological Disorders - Drug Targets The Induction of Proinflammatory Cytokines in Response to Avian Influenza H5N1 Infections and their Role in Pathogenesis and the Enhancement of Virulence
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Recent Patents in CNS Drug Discovery: The Management of Inflammation in the Central Nervous System
Recent Patents on CNS Drug Discovery (Discontinued) Therapeutic Potential of Citronella Essential Oil: A Review
Current Drug Discovery Technologies Monocyte and Macrophage Dysfunction as a Cause of HIV-1 Induced Dysfunction of Innate Immunity
Current Molecular Medicine Disorders of Consciousness and Pharmaceuticals that Act on Oxygen Based Amino Acid and Monoamine Neurotransmitter Pathways of the Brain
Current Pharmaceutical Design Unravelling the Role of Infectious Agents in the Pathogenesis of Human Autoimmunity: The Hypothesis of the Retroviral Involvement Revisited
Current Molecular Medicine Pathogens and Chronic or Long-Term Neurologic Disorders
Cardiovascular & Hematological Disorders-Drug Targets Place of Nanofiltration for Assuring Viral Safety of Biologicals
Current Nanoscience The Immune System of Cancer Patients
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry